Urine Omics Predicting IO Therapy Responses in mRCC Patients

Clinical trial NCT04712305 · RECRUITING

Trial details

NCT number: NCT04712305
Sponsor: National Taiwan University Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Metastatic Renal Cell Carcinoma

Start date: 2021-01-04
Primary completion: 2025-12-31
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.